Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2002

Study Completion Date

June 30, 2004

Conditions

HIV InfectionsHepatitis C, ChronicTreatment Failure

Interventions

DRUG

Peginterferon alfa2a

DRUG

Ribavirin

Trial Locations (1)

Hôpital Pellegrin, Federation des Maladies Infectieuses, Pr RAGNAUD, Bordeaux

All Listed Sponsors

collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

Ministry of Health, France

OTHER_GOV

lead

University Hospital, Bordeaux

OTHER

NCT00221650 - Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients | Biotech Hunter | Biotech Hunter